Patents Assigned to Androsolutions, Inc.
  • Patent number: 6559184
    Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising: (a) a prostaglandin vasodilator; (b) 15-hydroxyprostaglandindehydrogenase inhibitor: and (c) a base material that is solid at room temperature and releases components (a) and (b) when inserted in the urethra, is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: May 6, 2003
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Patent number: 6414027
    Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising: (a) a prostaglandin vasodilator; (b) 15-hydroxyprostaglandindehydrogenase inhibitor; and (c) a base material that is solid at room temperature and releases components (a) and (b) when inserted in the urethra, is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: July 2, 2002
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Patent number: 6410595
    Abstract: Administration of a pharmaceutical composition comprising: (a) a vasodilator; and (b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: June 25, 2002
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal
  • Patent number: 6103765
    Abstract: Administration of a pharmaceutical composition comprising:(a) a vasodilator; and(b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.
    Type: Grant
    Filed: July 9, 1997
    Date of Patent: August 15, 2000
    Assignee: Androsolutions, Inc.
    Inventor: Gary W. Neal